FI963682A0 - Use of dimethicone for the prevention and treatment of topical antibacterial therapy and / or syndromes and infectious diseases associated with Helicobacter pylori (HP) - Google Patents

Use of dimethicone for the prevention and treatment of topical antibacterial therapy and / or syndromes and infectious diseases associated with Helicobacter pylori (HP)

Info

Publication number
FI963682A0
FI963682A0 FI963682A FI963682A FI963682A0 FI 963682 A0 FI963682 A0 FI 963682A0 FI 963682 A FI963682 A FI 963682A FI 963682 A FI963682 A FI 963682A FI 963682 A0 FI963682 A0 FI 963682A0
Authority
FI
Finland
Prior art keywords
dimethicone
syndromes
prevention
treatment
infectious diseases
Prior art date
Application number
FI963682A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI963682A (en
Inventor
Alfred Schmidt
Hans-Juergen Upmeyer
Original Assignee
Alfred Schmidt
Upmeyer Hans Juergen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP1995/000972 external-priority patent/WO1995025525A1/en
Application filed by Alfred Schmidt, Upmeyer Hans Juergen filed Critical Alfred Schmidt
Publication of FI963682A0 publication Critical patent/FI963682A0/en
Publication of FI963682A publication Critical patent/FI963682A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI963682A 1994-03-18 1996-09-17 Use of dimeticone for local antibacterial therapy and / or prevention and therapy of Helicobacter pylori (HP) syndrome and infectious diseases FI963682A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4409357A DE4409357C2 (en) 1994-03-18 1994-03-18 Use of Dimeticon to eradicate Heliobacter pylori
PCT/EP1995/000972 WO1995025525A1 (en) 1994-03-18 1995-03-15 The use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (hp) associated syndromes and infectious diseases

Publications (2)

Publication Number Publication Date
FI963682A0 true FI963682A0 (en) 1996-09-17
FI963682A FI963682A (en) 1996-11-13

Family

ID=6513210

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963682A FI963682A (en) 1994-03-18 1996-09-17 Use of dimeticone for local antibacterial therapy and / or prevention and therapy of Helicobacter pylori (HP) syndrome and infectious diseases

Country Status (14)

Country Link
EP (1) EP0804242A1 (en)
JP (1) JPH09510466A (en)
CN (1) CN1244129A (en)
AU (1) AU699199B2 (en)
CA (1) CA2185882A1 (en)
CZ (1) CZ300796A3 (en)
DE (1) DE4409357C2 (en)
FI (1) FI963682A (en)
HU (1) HU215595B (en)
NO (1) NO963893L (en)
NZ (1) NZ282805A (en)
PL (1) PL316307A1 (en)
SK (1) SK132496A3 (en)
WO (1) WO1995025545A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100245A (en) * 1999-09-07 2000-08-08 Mcneil-Ppc, Inc. Use of simethicone to treat ulcerative colitis
BR0318319A (en) * 2003-05-25 2006-07-18 Yuwan Wang preparation methods and formulations / compositions sustained by the use of dimethicone as a vehicle

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3848M (en) * 1964-05-04 1966-01-17 Robert Schapiro Therapeutic associations for the treatment of numerous organic or functional digestive disorders.
GB1357737A (en) * 1970-10-09 1974-06-26 Arpic Sa Sustained release pharmaceutical compositions
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
US4837029A (en) * 1987-04-06 1989-06-06 Carolina Medical Products, Inc. Low foaming, aqueously homogenizable rifampin composition
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
WO1990007930A1 (en) * 1989-01-19 1990-07-26 Steigerwald Arzneimittelwerk Gmbh Use of dimethylpolysiloxane for treating disorders of the gastrointestinal tract
IE903302A1 (en) * 1989-09-15 1991-04-10 Pehrom Pharmaceutical Corp Topical preparation for treatment of aphthous ulcers and¹other lesions
NZ235876A (en) * 1989-11-01 1992-06-25 Mcneil Ppc Inc Pharmaceutical compositions containing effective amount of antidiarrheal composition and antiflatulent effective amount of simethicone
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn
WO1994003209A1 (en) * 1992-07-29 1994-02-17 Merck & Co., Inc. Dexibuprofen/antacid/simethicone combinations

Also Published As

Publication number Publication date
PL316307A1 (en) 1997-01-06
HUT75711A (en) 1997-05-28
NZ282805A (en) 1998-02-26
CN1244129A (en) 2000-02-09
EP0804242A1 (en) 1997-11-05
NO963893D0 (en) 1996-09-17
AU2071395A (en) 1995-10-09
SK132496A3 (en) 1997-06-04
NO963893L (en) 1996-11-04
HU9602839D0 (en) 1996-12-30
CZ300796A3 (en) 1997-09-17
DE4409357C2 (en) 1996-10-17
JPH09510466A (en) 1997-10-21
HU215595B (en) 1999-01-28
CA2185882A1 (en) 1995-09-28
DE4409357A1 (en) 1995-09-21
WO1995025545A1 (en) 1995-09-28
AU699199B2 (en) 1998-11-26
FI963682A (en) 1996-11-13

Similar Documents

Publication Publication Date Title
FI963281A0 (en) Urease-based vaccine and treatment of Helicobacter pylori infection
PL344535A1 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections
FI935591A0 (en) Oral therapy for Helicobacter infection
FI971969A0 (en) Compositions and method of use for the treatment of hemorrhoids
DE59406123D1 (en) HAIR TREATMENT
NO990225D0 (en) Medications for the treatment of hyperphosphatemia
DK19893A (en) NASAL TREATMENT PREPARATION
AU1197992A (en) The use of loperamide and related compounds for treatment of respiratory disease symptoms
IS4466A (en) Composition and treatment for multiple sclerosis
NO983465D0 (en) Pharmaceuticals Surface Combination Preparations Containing LHRH Analogues and Anti-Strogens for the Treatment of Gynecological Disorders
PT928193E (en) USE OF 1-HYDROXY-2-PYRIDONES FOR THE TREATMENT OF SKIN INFECTIONS
NO961226L (en) Compounds for the prevention and treatment of viral-induced tumors
HU9602841D0 (en) The use of dimeticone for the local antibacterial therapy and/or the prevention and of helicobacter pylori (hp) associated syndromes and infectious diseases
FI963682A0 (en) Use of dimethicone for the prevention and treatment of topical antibacterial therapy and / or syndromes and infectious diseases associated with Helicobacter pylori (HP)
ZA952839B (en) Treatment of H pylori infections
BR9407197A (en) Pharmaceutical composition for immunomodulatory and adjuvant treatment
NO970185D0 (en) Use of (S) -adenosyl-L-methionine (SAMe) and its physiologically compatible salts for the treatment of reperfusion injury triggered by temporal-focal ischemia
FI961869A (en) Vaccine design and manufacture
BR9303545A (en) Procedure for the treatment and shaping of hair
KR950003086U (en) Infrared Therapy for Medical Science
NO920204D0 (en) PHARMACEUTICAL PREPARATION AND PROCEDURE FOR ITS PREPARATION
ITTO950545A0 (en) HELYCOBACTER PYLORI VACCINE/THERAPEUTIC COMPOSITIONS, THEIR PREPARATION AND USE.
SE9303800D0 (en) Dental treatment Protection
FR2713485B1 (en) Medicinal product intended to protect and / or regenerate the intestinal mucosa.
NO920063L (en) PHARMACEUTICAL PREPARATION AND ITS USE